Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C

OBJECTIVES: The overall goal of the Kentucky Viral Hepatitis Treatment Study (KeY Treat) is to eliminate hepatitis C transmission from a county in Appalachian Kentucky by removing the barriers to accessing hepatitis C virus (HCV) treatment. METHODS/ANALYSIS: KeY Treat is a phase IV, open-label, sing...

Descripción completa

Detalles Bibliográficos
Autores principales: Havens, Jennifer R, Schaninger, Takako, Fraser, Hannah, Lofwall, Michelle, Staton, Michele, Young, April M, Hoven, Ardis, Walsh, Sharon L, Vickerman, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258565/
https://www.ncbi.nlm.nih.gov/pubmed/34226208
http://dx.doi.org/10.1136/bmjopen-2020-041490

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258565/
https://www.ncbi.nlm.nih.gov/pubmed/34226208
http://dx.doi.org/10.1136/bmjopen-2020-041490

Ejemplares similares